Drug Shortage Report for APO-MONTELUKAST

Last updated on 2023-03-30 History
Report ID 187241
Drug Identification Number 02374609
Brand name APO-MONTELUKAST
Common or Proper name MONTELUKAST
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 90 BTL
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-03-14
Estimated end date 2023-03-31
Actual end date 2023-03-24
Shortage status Resolved
Updated date 2023-03-30
Company comments 30 BLS available
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2023-03-30 French Compare
v7 2023-03-30 English Compare
v6 2023-03-23 French Compare
v5 2023-03-23 English Compare
v4 2023-03-23 French Compare
v3 2023-03-23 English Compare
v2 2023-03-16 French Compare
v1 2023-03-16 English Compare

Showing 1 to 8 of 8